Thyroxine induces pancreatic beta cell apoptosis in rats

Area of Science:

• Endocrinology
• Cell Biology
• Metabolic Research

Background:

• Thyroid hormones are known to decrease glucose tolerance in humans and animals.
• This metabolic effect is associated with a diminished beta-cell volume in the pancreas.

Purpose of the Study:

• To investigate the cellular mechanisms by which thyroid hormones reduce pancreatic beta-cell volume.
• To explore the role of apoptosis and proliferation in thyroid hormone-induced changes in beta-cell mass.

Main Methods:

• Terminal UTP nick end labelling (TUNEL) assay to detect apoptosis.
• Caspase-3 activity measurement to quantify apoptosis.
• Bromodeoxyuridine (BrdU) labelling to assess beta-cell proliferation.

Main Results:

• Thyroxine treatment significantly increased beta-cell apoptosis, evidenced by elevated TUNEL and caspase-3 positive cells.
• Apoptosis also increased in pancreatic ductal cells, potential stem cells for beta cells.
• Withdrawal of thyroxine led to increased beta-cell replication, indicated by higher BrdU labelling.

Conclusions:

• Increased beta-cell apoptosis in hyperthyroidism contributes to reduced insulin content and secretion.
• The decrease in beta-cell mass due to apoptosis explains the impaired glucose tolerance observed in hyperthyroid states.
• Thyroid hormone-induced effects on beta cells are reversible, highlighting the dynamic nature of beta-cell mass regulation.